NCNA (NCNA) Stock Price & Analysis
NCNA (NCNA) fell 2.10% to USD 1.4 as of September 8, 2026 at 09:36 UTC, according to Nexqual real-time market data.
NCNA last closed at USD 1.4; the session ranged USD 1.38–1.42 on volume of 32,172 shares. Market capitalization is —, with a 52-week range of USD 1.21–7.22 (NCM). Source: Nexqual, September 8, 2026 at 09:36 UTC.
Key Statistics (as of September 8, 2026 at 09:36 UTC)
| Price | USD 1.4 |
|---|---|
| Change | ▼ 2.10% (down) |
| Previous Close | USD 1.4 |
| Open | USD 1.4 |
| Day Range | USD 1.38 – 1.42 |
| 52-Week Range | USD 1.21 – 7.22 |
| Volume | 32,172 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (NCNA)
Nexqual's technical model rates NCNA "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 09:36 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 47.77 (neutral) |
| vs SMA50 | Below (USD 1.41) |
| MACD | -0 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MBIO | Mustang Bio, Inc. | USD 0.54 | ▼ 0.02% |
| GLMD | Galmed Pharmaceuticals Ltd. | USD 3.88 | ▼ 5.8% |
| TLPH | Talphera, Inc. | USD 1.2 | ▲ 0% |
| ADIL | Adial Pharmaceuticals, Inc | USD 7.12 | ▲ 12.66% |
| PHIO | Phio Pharmaceuticals Corp. | USD 1.08 | ▼ 4.42% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:36 UTC. This page is informational and not investment advice.